We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.1B
AUM Growth
–
Cap. Flow
+$84.5B
Cap. Flow
% of AUM
104.29%
Top 10 Holdings %
Top 10 Hldgs %
15.07%
Holding
1,945
New
1,945
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Thermo Fisher Scientific
TMO
|
+$1.34B |
| 4 |
Synopsys
SNPS
|
+$1.29B |
| 5 |
NVIDIA
NVDA
|
+$1.24B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Healthcare | 16% |
| 3 | Industrials | 15.5% |
| 4 | Consumer Discretionary | 8.77% |
| 5 | Utilities | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sonoco
SON
$5.71B
| $45.8M | 0.06% |
+842,133
| New | +$47.7M |
|
302
Medpace
MEDP
$16.9B
| $45.5M | 0.06% |
+187,909
| New | +$48.1M |
|
303
Cooper Companies
COO
$15B
| $45.4M | 0.06% |
+571,472
| New | +$52.7M |
|
304
Axsome Therapeutics
AXSM
$11.3B
| $45.2M | 0.06% |
+646,429
| New | +$48.3M |
|
305
Royal Bank of Canada
RY
$292B
| $44.3M | 0.05% |
+504,523
| New | +$46.9M |
|
306
CRH
CRH
$67.4B
| $43.9M | 0.05% |
+802,474
| New | +$45.6M |
|
307
Immunovant
IMVT
$8.45B
| $43.6M | 0.05% |
+1,135,205
| New | +$25.7M |
|
308
Krystal Biotech
KRYS
$9.68B
| $43.4M | 0.05% |
+373,812
| New | +$45.6M |
|
309
Ametek
AME
$58.8B
| $43.3M | 0.05% |
+293,148
| New | +$45.8M |
|
310
Live Nation Entertainment
LYV
$42.7B
| $43.3M | 0.05% |
+520,942
| New | +$45.4M |
|
311
RTX Corp
RTX
$302B
| $43.1M | 0.05% |
+599,236
| New | +$51.3M |
|
312
CVS Health
CVS
$120B
| $42.7M | 0.05% |
+611,265
| New | +$43.3M |
|
313
Manulife Financial
MFC
$72.7B
| $42.6M | 0.05% |
+2,321,863
| New | +$43.9M |
|
314
Exelixis
EXEL
$12.7B
| $42.4M | 0.05% |
+1,942,488
| New | +$40.6M |
|
315
Chubb
CB
$134B
| $42.3M | 0.05% |
+203,397
| New | +$41.1M |
|
|
SCHW
316
Charles Schwab
SCHW
$186B
| $42.3M | 0.05% |
+769,752
| New | +$46.5M |
|
317
Progressive
PGR
$123B
| $42M | 0.05% |
+301,775
| New | +$39.7M |
|
318
Boeing
BA
$184B
| $41.5M | 0.05% |
+216,692
| New | +$47.4M |
|
319
W.W. Grainger
GWW
$61.3B
| $41.4M | 0.05% |
+59,828
| New | +$43.3M |
|
320
Chemed
CHE
$7.02B
| $41M | 0.05% |
+78,981
| New | +$41.1M |
|
|
EA
321
DELISTED
Electronic Arts
EA
| $40.8M | 0.05% |
+338,683
| New | +$42.6M |
|
322
Stryker
SYK
$134B
| $40.8M | 0.05% |
+149,215
| New | +$42.8M |
|
323
Fastenal
FAST
$60.1B
| $40.1M | 0.05% |
+1,468,714
| New | +$41.7M |
|
324
Brown-Forman Class B
BF.B
$12.9B
| $39.7M | 0.05% |
+688,420
| New | +$45.8M |
|
325
American Tower
AMT
$79B
| $38.7M | 0.05% |
+235,355
| New | +$43M |
|
Similar funds
Pictet Asset Management's Q3 2023 Portfolio in Review
Q3 2023 is the first quarter with a 13F filing on record for Pictet Asset Management, which disclosed 1,945 positions worth $81.1B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Microsoft: 5,754,059 shares worth $1.82B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Healthcare and Industrials.
- Pictet Asset Management's largest Q3 2023 buy was Microsoft: 5,754,059 shares worth $1.82B.
- Pictet Asset Management's ten largest holdings make up 15% of its $81.1B portfolio in Q3 2023.
- Pictet Asset Management disclosed 1,945 positions in Q3 2023, its first 13F filing on record.
Based on Pictet Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.